Katherine Roden, MD
Interventional Pain Medicine · Lexington, KYNPI 1982967824
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,336 of the $4,118 with a category attached, or 81.0%. 14 manufacturers reported payments, led by Boston Scientific at 43.9% of the total.
Across 177 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$2K
- Medtronic$136
- Pfizer$66
- Novartis$48
- Pacira Therapeutics, Inc.$42
- plus $211 from 8 others
What the payments were for
- Travel & lodging$78219%
- Food & beverage$3,33681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 29 | $1,809 |
| AbbVie(2 entities) | 121 | $1,806 |
| Medtronic(2 entities) | 7 | $136 |
| Pfizer | 4 | $66 |
| Novartis | 2 | $48 |
| Pacira Therapeutics, Inc. | 2 | $42 |
| Biodelivery Sciences International, Inc. | 3 | $37 |
| SPR Therapeutics, Inc | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Abbott | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| MML US, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$803
How this compares
$4,118 in reported general payments places this provider in the 55th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 998 | $15,314 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 11 | $7,935 |
| Gabapentin | 493 | $6,384 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 212 | $4,431 |
| Pregabalin | 154 | $2,767 |
| Oxycodone Hcl | 113 | $1,944 |
| Morphine Sulfate | 69 | $1,827 |
| Tramadol Hcl | 242 | $1,779 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $1,443 |
| Diclofenac Sodium | 47 | $732 |
| Methocarbamol | 78 | $561 |
| Celecoxib | 17 | $431 |
| Baclofen | 50 | $425 |
| Duloxetine Hcl | 27 | $425 |
| Cyclobenzaprine Hcl | 78 | $404 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lexington
- Anand ModaduguLexington$12K
- Brock MarrsLexington$9K
- Rebecca FreelandLexington$4K
- Saroj DubalLexington$4K
- Lauren LarsonLexington$2K
- Zbigniew RogozinskiLexington$1K
- Ihab LabatiaLexington$696
- Peter WrightLexington$123
- William WittLexington$98
- Robert KlickovichFlorence$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.